Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If defending my friend with truth about her honesty strips away my credibility, then by all means strip away. I stand by my comments. Since she is stripped of her rights to defend herself I consider it a privilege to do so for her.
As for the personal info, it is my understanding that a country was named after personal info was posted about Misiu. But I am stating info passed on from Misiu to me. Besides who would believe me, a person with no credibility.
Posting--doxxing with personal information is not "insensitive remark"
You and dolphin have lost all credibility with your nonsense today. But in your case you didn't ever really have any. But make sure and double down in case someone might still be giving you benefit of doubt--kudos for removing ALL credibilty
Well, I believed in Healthsouth and talked it up a lot. Had no idea the CEO was a freaking ********. And Enron - told my friends about it. Many others. It doesn’t matter how much one talks about a scam that is disguised as a bonafide stock does it? We all are snookered. I mean we on this board know beyond a reasonable doubt that Leronlimab has saved lives who were on their death bed. And yet others, here, say the opposite. Is it a scam?
Your opinion on another’s investment is just an opinion, thank heavens. But suppose you are incorrect? And now, today, your remark leaps the tallest building while she
Can’t even defend herself here.
Probably, in this instance, good because an admin would come along and kick her off for good all because of an insensitive remark.
i say we are years from revenue, and thus years from a much higher share price. unless mice start paying for drugs.
as such, i'll take .50 anytime this year. but you're right, you vote your way and i'll vote mine.
the other thing i will vote against, is every board member. they are a disaster from top to bottom - especially at the top.
Did not what? Didn't post a privacy violation about another poster?
Yes she did.
No. But I wonder if you wrote about them with as much conviction as she did.
Depends on which team you are on.
I also was in 2 of the stocks that Misiu was in that ended up going to pinkville heaven (?) (Hell?). She and I both lost money in it but then we were in one that paid a special dividend. Misiu took the dividend and reinvested it into the stock, such a believer on it she was. I did not.
This has nothing to do with honesty.
Her political beliefs are point in case. I am certain that there are people on this board who support Trump. They listen to Fox. I view those views (many) as lies, like eating pets. Does that make the person who repeats those lies a liar? No. It makes them (imo) misinformed.
So, again, Misiu is not the originator of lies.
I’ve been in a number of different scams over the years too. Does that make me a liar or one that is untrustworthy? I hope not.
I absolutely agree with you.
As she should be. Posting personal shareholder info--whether it is correct info or not is nonsense. Something a child would do and not understand why it is wrong
I have posted about some of the paid PR firms that the former CEO employed. That info was public data found on OTC Mkt disclosure page. At 1 time there were a dozen paid pump PR firms and however many fraud posters they employed pasting posting for a fraud coverup. EVERY one of those individuals--firms should be prosecuted for the out and out lies they stated as FACT. The fake author/chessmaster on zerohedge etc. Even the facebook website was/is run by a paid promoter--Chris Lonsford which FINALLY got exposed in a SEC filed doc during the 13 D "battle". I can post pages of lies that the CYDY "minions" posted about during that time. Miss Hooey/phooey/sooey was leading the charge of that nonsense. Not opinion--FACT
She even posted she heard--had audio tape recording of 13 D head saying they would buy Dr Patterson company IncellDX. Out and out lie. Then when called out for that LIE it is her go to the dodge/deflect/defer to start about Incell "investors" losing money and ANY defender of 13 D group was invested in IncellDX. Just rubbish
The reason the ban crap makes ZERO sense is miss hooey/sooey often posted on BIXT board (where mike sheikh is employed BTW) and a couple other IHUB boards. ANYONE can easily see she has not posted on those either. Click profile. Look at post history
Once again just made up nonsense.
If she lied about you I can only speculate that whatever "lie" she said was something that came from someone else.
You'd be wrong about that. I don't know her just from this stock. She's been in a number of different scams over the years.
Janice, I only replied to your posts. You initially replied to me about my (misstatement) comment about her being banned for life.
You were a big help in having me (us) understand the intricacies of her banishment.
I think she has been able to contact Shelly now so thanks again. I will not reply further to your comments to me.
I have no knowledge of your relationship with her, I can only speak of my relationship with her.
As I said before she has had some choice comments to me because I am a never Trumper but never have I heard a lie about me come from her. If she lied about you I can only speculate that whatever "lie" she said was something that came from someone else. Again, that is my personal experience with her which is why I 100% know that her experience with Leronlimab and her son is the God's honest truth. But that is a dead horse that has been pulverized.
I will go back into hibernation now.
Peace, out.
...but I will vouch for her honesty.
I will not. She's certainly tried to retail plenty of lies about me. I came to this board was because she was trashing me.
Further, I don't understand why you keep posting to me. I AM NOT AN ADMIN. There is nothing I can do about this.
Well, I only know she can not contact her now. You can believe what you wish, but I will vouch for her honesty. She is passionate about her beliefs be they medicine or politics and she and I do not share the same political ideology but I have seen in 15 + years her charitable and generous heart.
If you could offer me an email address for her to contact Shelly. I would greatly appreciate it.
It seems a shame to me that the largest shareholder in the room is banned from posting for what has been, what? 7 months?
If one were a conspiracy theorist, one might speculate that those with nefarious goals were keeping the largest shareholder from having a voice.
But, like you (I assume) I have no skin in the game (well, a few skin cells maybe).
Thanks again.
I think your right that he is trying to get cydy on tract,but tanya and other board memvers have him shackled. Right now there is no clear path to success. No path to cancer trials and no orher company helping us
She is banned from this board until further notice, as I said.
My guess is that she PM'd Shelly a number of times, but didn't get the response she wanted.
She is unable to do that. The reason I think, that she was trying to contact you is that she is reading these messages and you are the only one of "importance" who has responded.
So, for verification, she is not banned from IHUB but she is banned from this board for life?
I think she would like to contact administrators about this. Since she is unable to do it through the site, is there an email for admin? They did not respond to me, evidently because I am not the involved party.
I appreciate your patience and help in this matter.
Friday between 4 and 5. Again, why would she write to me? I have nothing to do with it. She needs to contact an admin. And for that, she doesn't need to have a paid account.
She is not a paying member I don't think.
When is happy hour?
Yes. That is what I said. Twice, I believe.
Misiu just texted me that she tried to contact you but got the message that she can not because she is banned.
That is nonsense. I'm only a moderator on this board; not an admin. Anyone who's a paying member--or who waits till Happy Hour--can send me a PM. But I didn't ban her, so I don't see what I could do.
And in case she's confused, I am not Shelly the Admin.
Is she still banned from this board?
Janice, Misiu just texted me that she tried to contact you but got the message that she can not because she is banned. Can you investigate this? Greatly appreciated.
She knows what she needs to do. She posted personal information; that's why she was initially jailed, and also banned from this board.
Thank you Janice. I will tell her. She evidently is having difficulty getting in. Should I advise her to contact admin?
Regardless --it is possible he was told that "lifetime ban" story/not knowing any better/ believing his 'friend"--so he is just repeating but doesn't make it true
Yes. I wondered the same thing. But she is banned from posting on this board until further notice. I just checked.
Unfortunately she has been barred from IHUB for life.
Are you sure about that? Originally, her account was suspended until sometime in August. Now, she's been sprung from IHub Jail. Seems to me she should be able to post again on this board.
After all, when a member is banned from the site, an image of a boot appears in his or her profile. Misiu has not been booted:
https://investorshub.advfn.com/boards/profilea.aspx?user=30391
How pathetic you sound.
Dr Lalezari is delivering on his plan. In turn, he is bringing credibility back and is preparing to move Leronlimab into the clinic, and into partnerships for multiple indications. Your five year projection is, to say the least, an exaggeration. Your whining cannot destroy the positive developments that are currently taking place. Yes, he took the company over when it was almost completely destroyed. However, under his leadership, more positive steps have been taken, to position us for success, than have been taken since the company's beginning. This management team is moving forward with building credibility, and establishing opportunities to move Leronlimab back into the clinic with well planned protocols and financing. I appreciate that they cannot make mistakes. You should have patience, and soon you will be able to sell your shares for 50 cents each. Good luck to you. Personally, I still believe the value will go much higher.
Sorry. That is my bad. I take full responsibility. Misiu never said lifetime ban, I did. She said that she thought she was banned for 6 months but that date passed in August so I assumed it was lifetime.
Glad to hear it. I contacted admin and asked but have not heard back.
I understand that you feel that everything you hear is a lie. I have known people like that. They have been lied to their entire life so they trust no one. You have my utmost sympathy.
Thanks for the information about the boot. That gives me some hope she will be back. BTW she was also unaware.
Perhaps if someone else here can contact administrators between one of us we may get an answer.
That is 100% true--it shows the "ban" and it shows when a "ban" is over
Tom is given the benefit of the doubt (was credible back in the day) but why would anyone be on a phone the whole time a child is in the hospital ICU--sorta strange
Regardless --it is possible he was told that "lifetime ban" story/not knowing any better/ believing his 'friend"--so he is just repeating but doesn't make it true
The witness list for the former ceo trial might be more indicative of why some may have "disappeared"
You will notice the sheikh of nodderspeak--the former resource unlimited guy that nodder used for many fraud articles-- the zerohedge chessmstr stuff plus. He is there along with several others. Hope they ALL get prosecuted along with kickback khazempourhassan
Tom, Tom, Tom....I just don't understand why you all tell lies?
https://investorshub.advfn.com/boards/profilea.aspx?user=30391
She HAS NOT been barred for life. There would be a boot next to her name. She was in jail for a while for posting someone's personal info, but she's out.... she could post here whenever she wants. She is just too ashamed to. Or embarrassed.....or.....maybe you aren't such great friends that she didn't tell you?
At $.50, i would vote all of my shares for a sale of the company right now - I'm sure I'm not alone. I'm not saying there isn't the potential for a higher share price at some point (there likely is), but given that this has been a train wreck for over 10 years, and given that we're only back at square one in terms of figuring out if we have any indications that have potential, getting $.50 anytime in the next year would be a home run. Remember, taking a pre-revenue biotech from start to finish is a 10 year process - and we just did a complete re-boot.
To be clear, i'm not saying we couldn't see $1 at some point - but that will require great data from real human trials - likely another 5 years at least. And I really would rather not have to watch the CYDY ticker for another 5-10 years.
Misiu is a friend of mine. It was her son that was cured and I was on the phone with her while she was going through that horrible experience. I can verify that the episode was 100% true.
Unfortunately she has been barred from IHUB for life. I have been trying to contact Admin for her to find out why.
I am not in the stock (except for a few shares) currently but I believe in the science and I 100% believe in the honesty and integrity of Misiu.
If anyone here can help me with this. I would appreciate it.
I plan on buying more CYDY when my RA tells me to.
Announcement to all short thinkers and other such foolish analysis (lol). GIVE ME MORE CHEAPIES....
What happened to the tactics? Let's get it down some more. Hurry, money burning a hole in my pocket.
Leronlimab!! Know what you own. CytoDyn, vastly improved, not perfect but getting there. Now did I say
partners coming? OMG
$CYDY$ 2024 Good job team, keep improving.
Ah ah ah
All her lies got debunked over these 5 years, one by one. Every. One. Of. Them.
She made one false promise every month. Every month!
There is not a single one of them which ended up correct.
It’s really hard to get 60 predictions wrong.
She did it.
I wonder how that "doctor" is doing who had "proof" that CYDY had a "cure" for Covid, based on a sample of 1 person coincidentally recovering.
Must've gone to a DIY medical "school".
Why is turnover rate so high for a company that supposedly owns a miracle molecule that will redefine medicine?
Looking Good 👍
What type of track has tayna put us on. Not sure how you value your money. Under tayna me have lost ofer 60 per cent. We have no clear path to get a deal or advanced clinical tests. We have burn rate close to million a month. This is utter failure. Plus paulson keeps getting richer under her. Dr. Jay good guy but shackled by her and board. Lets get a directo that cares about shareholders. Someone with scientific experience.
Ahmm the greatest.
Massive green all over the market! Oh... Yeeaaahhhh, sorry CYDY, well at least you're up 0.1% LAUGHING
Way more long and way more knowledgeable. These short fools have run out of ammunition and are now trying to find some low hanging fruit.
I have never said Tanya is the greatest, but is part of the team that has put us back on track. Only shorts and paid bashers from some competing source dedicate themselves to attacking posters and a stock. Leronlimab poses a great threat to many a club member with big friends with tons tied
up in a lot of companies. Plain and simple that these types try to camouflage themselves as fake longs.
$$$CYDY$$$ 2024 Good job team!!
You don’t think we have pounded sand on this board?
You think we would like to hug that stupido BOD?
Where’ve you been lately..,
you've lost me. what does the number of chat board posts have to do with whether someone is long? I'd argue the opposite. You have clowns like fungderf who have admitted they have no stake - and they post 25 times a day. i think there are a good number of paid promoters or bashers on here - and the more daily posts, the more likely that's what they are.
my point is that if you've truly been long this stock - and lost most of your money - how can you not be frustrated and pushing for a greater sense of urgency from management and the board.
Followers
|
814
|
Posters
|
|
Posts (Today)
|
2
|
Posts (Total)
|
233522
|
Created
|
11/18/05
|
Type
|
Free
|
Moderators janice shell kgromax |
DISCLAIMER:
Securities and Exchange Commission and Department of Justice Investigations
The Company has received subpoenas from the United States Securities and Exchange Commission requesting documents and information concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19 and related communications with the FDA, investors, and others, and trading in the securities of CytoDyn. The SEC has informed the Company that this inquiry should not be construed as an indication that any violations of law have occurred or that the SEC has any negative opinion of any person, entity or securities trading activity.
In addition, the Company and certain of its executives have received subpoenas in connection with an investigation being conducted by the United States Department of Justice. The subpoenas seek testimony and/or records concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19 and related communications with the FDA, investors, and others, and trading in the securities of CytoDyn.
Securities and Exchange Commission and Department of Justice Investigations
The Company has received subpoenas from the United States Securities and Exchange Commission (“SEC”) and the United States Department of Justice (“DOJ”) requesting documents and information concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19, HIV, and triple-negative breast cancer, related communications with the FDA, investors, and others, litigation involving former employees, the Company’s retention of investor relations consultants, and trading in the Company’s securities. Certain Company executives have received subpoenas concerning similar issues and may be interviewed by the DOJ or SEC in the future. The SEC informed the Company that its inquiry should not be construed as an indication that any violations of law have occurred or that the SEC has any negative opinion of any person, entity or security.
The Company is cooperating fully with these non-public, fact-finding investigations, and as of the date of this filing, the Company is unable to predict the ultimate outcome and cannot reasonably estimate the potential possible loss or range of loss, if any.
VANCOUVER, Washington, March 30, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its HIV program and a full clinical hold on its COVID-19 program in the United States. Further, the Company elected to pause its Brazil COVID-19 trials pending results from its previously scheduled data safety monitoring committee meeting and is in the process of reevaluating the timing of its HIV BLA resubmission.
The Company was not enrolling any new patients in the trials placed on hold in the United States. The partial clinical hold on the HIV program impacts patients currently enrolled in extension trials. These patients will be transitioned to other available therapeutics and no clinical studies can be initiated or resumed until the partial clinical hold is resolved. CytoDyn intends to work closely with the FDA to resolve the partial clinical hold as soon as possible. Under the full clinical hold on the COVID-19 program, no new clinical studies may be initiated until the clinical hold is resolved. The Company is not currently conducting any COVID-19 trials in the United States, as it is evaluating the most optimal programs on which to focus its resources and attention.
“CytoDyn is committed to FDA compliance,” said Scott A. Kelly, M.D., Chief Medical Officer of CytoDyn. “We are evaluating our clinical programs and are working to resolve the issues underlying the clinical holds as soon as possible in close communication with the FDA. We will provide an update when we have additional information.”
Up to 205,652,848 Shares of Common Stock
This prospectus supplement updates, amends and supplements the prospectus dated October 11, 2023, relating to our Registration Statement on Form S-1 (Registration No. 333-272815) (as supplemented or amended from time to time, the “Prospectus”). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.
This prospectus supplement is being filed to supplement the Prospectus with the following information:
The information in this prospectus supplement includes forward-looking statements relating to, among other things, future clinical trials and our business strategy. The reader is cautioned not to rely on these statements, which are based on our current expectations. Please see below for additional information about risks involving our securities.
This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference. The Prospectus, together with this prospectus supplement, relates to the resale of up to 74,903,789 shares of our common stock, par value $0.001 per share (the “common stock”), and 130,749,059 shares of our common stock underlying certain warrants (collectively, the “Shares”), by the selling stockholders identified in the Prospectus under “Selling Stockholders”.
Our common stock is quoted on the OTCQB of OTC Markets Group, Inc. under the symbol “CYDY.” On February 29, 2024 the closing price of our common stock was $0.2575 per share.
Investing in our securities involves risk. You should carefully consider the risks that we have described under the section captioned “Risk Factors” in the Prospectus on page 8 and in Part II, Item 1A of the 2024 Second Quarter 10-Q before buying our securities.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is March 1, 2024.
November 3, 2023
November 2023 Letter to Shareholders
Dear Shareholders,
We write to provide an update on CytoDyn Inc. (“CytoDyn” or “Company”), and to thank you for your continued support of the Company.
Throughout our history, CytoDyn has made great strides in developing leronlimab from a single indication molecule into a platform molecule with the potential for multiple therapeutic indications. Through CytoDyn’s investment in clinical trials, we have generated valuable data demonstrating how leronlimab might be used in HIV, oncology, metabolic dysfunction-associated steatohepatitis (“MASH” formerly “NASH”), and metabolic dysfunction-associated steatotic liver disease (“MASLD”). We have also successfully transferred our manufacturing technology allowing us to manufacture leronlimab at scale in preparation for clinical trials and potential FDA approval.
Fiscal year 2023 proved to be a very difficult year for CytoDyn. We had planned to be off clinical hold and back to conducting clinical trials by now. Unfortunately, to date, we have been delayed in our efforts to satisfy the FDA with our clinical hold submission(s). We have embarked on a more comprehensive effort to resolve the FDA’s lingering questions. These efforts include the Company’s hosting of a number of advisory board meetings with key opinion leaders (KOLs). Adding to our delay was the unanticipated medical leave taken by our then President, Dr. Arman creating additional delays in our subsequent resubmission.
However, these unforeseen circumstances provided the time needed to help us gain new insights and understanding of leronlimab in the current HIV treatment environment. Further, we were able to receive and incorporate the perspectives of some of the top HIV KOLs worldwide as to how they believe leronlimab can play a significant role in helping HIV patients, notwithstanding other therapeutic options currently available to patients. As part of this process, the Company engaged various new clinical, regulatory, and medical consultants and advisors with relevant experience and expertise that we believe will continue to benefit the Company for years to come.
The Company has taken necessary actions to position us for near-term and long-term success. During the last fiscal year, the Company implemented significant reductions to its workforce, cash burn rate, and operating expenses, in order to conserve our resources and devote them to critical corporate priorities. In addition to our work in HIV, we have worked with top experts to develop a MASH clinical trial protocol and identify potential MASH pre-clinical combination therapy trial concepts, which trials we believe could be attractive to a partner and position the Company for a greater chance of success within the MASH space. We also began development of a longer-acting therapeutic with a partner who has a very strong and reputable artificial intelligence (“AI”) platform, which we believe may provide significant increases in shareholder value in the years to come. We also believe that the Company is positioned for success in the Amarex litigation. We fully funded Sidley Austin LLP – the preeminent law firm representing the Company in this matter, filed a more-detailed statement of claim, and scheduled a final hearing date (August 12, 2024) in the arbitration.
We understand that CytoDyn’s recent challenges may have tested your confidence. We want to assure you that we remain dedicated to developing important therapeutics that can make a difference in
patients' lives, and at the same time provide value for our shareholders. Again, we are grateful for your ongoing support and trust.
We will continue our efforts to prioritize and execute on goals that will enhance value for all shareholders. Our efforts are focused on successfully completing the resolution of the FDA’s partial clinical hold – having recently made a submission that we hope will be successful – and strengthening our leadership team. Additionally, the Company will be evaluating the various potential indications for leronlimab to maximize the effective and efficient use of our resources. We have always believed leronlimab holds great promise, and we are determined to explore all avenues by which patients and medical practitioners can benefit from its use. We believe that with the improvements we have made and continue to pursue, our company is positioned for long-term success.
We deeply value your investment in CytoDyn and are committed to acting in your best interests. We look forward to continuing to communicate as additional developments occur. We realize the updates above may not answer all the questions you have. We therefore include a November 2023 “Frequently Asked Questions” supplement with this letter. This FAQ supplement is something we intend to update from time to time and it will be posted on the Company’s website in the near future.
Finally, in advance of our upcoming Annual Meeting on November 9, 2023, we want to remind you to submit your votes, if you have not already done so. If you were a shareholder as of September 11, 2023, you are considered a shareholder of record. Notably, the Company has asked for the shareholders’ approval to amend the Company’s Certificate of Incorporation to increase the total number of authorized shares of common stock. This increased share allowance is critical to the ongoing viability of the Company, and we therefore encourage everyone to vote if you have not already done so. If you have any questions or require any assistance in voting your shares, please call the Company’s proxy solicitor, Alliance Advisors LLC, at (833) 814-9456.
Sincerely,
Tanya Durkee Urbach
Board Chair
Note Regarding Forward-Looking Statements
This letter and the accompanying Frequently Asked Questions supplement contain forward-looking statements relating to, among other things, future operating and financial performance, product development, market position and business strategy. The reader is cautioned not to rely on these statements, which are based on current expectations of future events. For important information about these statements and/or our Company, including the risks, uncertainties and other factors that could cause actual results to vary materially from the assumptions, expectations and projections expressed in any forward-looking statements, the reader should review the Annual Report on Form 10-K for the fiscal year ended May 31, 2023, including in the sections captioned “Forward Looking Statements” and “Item 1A. Risk Factors”, as later supplemented by our Form 10-Q for the quarter ended August 31, 2023, in the section captioned “Item 1A. Risk Factors”. CytoDyn Inc. does not undertake to update any forward-looking statement as a result of new information or future events or developments.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |